Corvus Pharmaceuticals Announces Publication of Biochemistry and Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Modulate Tumor Immunity
GlobeNewswire
Data published in peer-reviewed npj Drug Discovery, a Nature portfolio journal
BURLINGAME, Calif., Dec. 04, 2024 (GLOBE..